How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Soft Medical Robot Market
- By Application: Surgical Assistance, Rehabilitation Therapy, Patient Monitoring and Care, Drug Delivery, Diagnostic Procedures
- By End-User: Hospitals, Rehabilitation Centers, Ambulatory Surgical Centers, Home Healthcare, Research and Academic Institutions
- By Technology: Soft Actuators, Flexible Sensors, Bio-Inspired Materials, Pneumatic Artificial Muscles, Hydrogel-Based Components
- By Control System: Teleoperated Systems, Autonomous Systems, Semi-Autonomous Systems, Haptic Feedback Systems
- By Robot Type: Soft Exoskeletons, Soft Surgical Robots, Soft Prosthetics, Soft Wearable Robots
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Surgical Assistance leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.182 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.190 →
Full report · locked preview
Everything inside the Soft Medical Robot Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Application 5
End-User 5
Technology 5
Control System 4
Robot Type 4
Companies profiled
Medtronic
Intuitive Surgical
Stryker Corporation
Zimmer Biomet Holdings
Smith & Nephew
Johnson & Johnson (Ethicon)
Boston Scientific
Verb Surgical (a collaboration between Verily and Johnson & Johnson)
Renishaw plc
TransEnterix (Asensus Surgical)
Aurora Spine Corporation
Titan Medical Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Intuitive Surgical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Zimmer Biomet Holdings
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Smith & Nephew
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Johnson & Johnson (Ethicon)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Boston Scientific
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Verb Surgical (a collaboration between Verily and Johnson & Johnson)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Renishaw plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →TransEnterix (Asensus Surgical)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Aurora Spine Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Titan Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Mazor Robotics (acquired by Medtronic)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Think Surgical Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Corindus Vascular Robotics (a Siemens Healthineers company)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,350M by 2033 · 7.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Surgical Assistance42.8
- Rehabilitation Therapy12.0
- Patient Monitoring and Care10.0
- Drug Delivery17.9
- Diagnostic Procedures17.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$996.0M → $1,812M · 7.8%
Europe$694.2M → $1,188M · 6.9%
Asia Pacific$633.8M → $1,114M · 7.3%
Latin America$392.4M → $685.5M · 7.2%
Middle East and Africa$301.8M → $562.9M · 8.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.362026
7.372027
7.392028
7.412029
7.422030
7.442031
7.432032
7.452033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic25.7
- Intuitive Surgical23.4
- Stryker Corporation6.4
- Zimmer Biomet Holdings4.6
- Smith & Nephew5.0
- Johnson & Johnson (Ethicon)6.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Application29.4%
End-User17.2%
Technology17.1%
Control System26.7%
Robot Type9.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.8
- Europe22.2
- Asia Pacific20.8
- Latin America12.8
- Middle East and Africa10.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 78 | 81 | 92 | 93 | 95 | 95 | 89 |
| Intuitive Surgical | 86 | 89 | 84 | 89 | 77 | 72 | 83 |
| Stryker Corporation | 73 | 72 | 75 | 79 | 84 | 69 | 75 |
| Zimmer Biomet Holdings | 68 | 70 | 65 | 64 | 74 | 60 | 67 |
| Smith & Nephew | 72 | 72 | 75 | 66 | 67 | 75 | 71 |
| Johnson & Johnson (Ethicon) | 54 | 63 | 46 | 58 | 54 | 57 | 55 |
| Boston Scientific | 57 | 60 | 48 | 66 | 44 | 49 | 54 |
| Verb Surgical (a collaboration between Verily and Johnson & Johnson) | 55 | 52 | 51 | 43 | 45 | 40 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- Intuitive Surgical
- Stryker Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Intuitive Surgical | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Stryker Corporation | ◐ | ◐ | ✓ | ✓ | ✓ | − |
| Zimmer Biomet Holdings | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Smith & Nephew | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Johnson & Johnson (Ethicon) | − | ✓ | ◐ | ◐ | ◐ | ◐ |
| Boston Scientific | ◐ | ◐ | − | ◐ | − | − |
| Verb Surgical (a collaboration between Verily and Johnson & Johnson) | ◐ | ◐ | ◐ | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic89
2Intuitive Surgical83
3Stryker Corporation75
4Smith & Nephew71
5Zimmer Biomet Holdings67
6Johnson & Johnson (Ethicon)55
7Boston Scientific54
8Verb Surgical (a collaboration between Verily and Johnson & Johnson)48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
MedtronicIntuitive Surgical
Challenger3
Strong scale, closing on the leaders.
Stryker CorporationZimmer Biomet HoldingsSmith & Nephew
Niche3
Specialists in a single segment or region.
Johnson & Johnson (Ethicon)Boston ScientificVerb Surgical (a collaboration between Verily and Johnson & Johnson)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Soft Medical Robot Market — a $349M beachhead inside a $5.24B market.
Beachhead (SOM)$349Mobtainable near-term
Serviceable (SAM)$2.09Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Surgical Assistance
Best fit — highest urgency & budget in Application.
Economic buyer78 fit
Rehabilitation Therapy
Strong fit — clear ROI and a fast path to value.
End user65 fit
Patient Monitoring and Care
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End-User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel28%
Digital / self-serve18%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Soft Medical Robot Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified26%
Evaluation12%
Closed-won6%
$17.7KCAC
$98KLTV
5.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Soft Medical Robot Market is a durable-growth opportunity — $8.32B by 2033, compounding at 9.3%.
TAM · 2025$4.09Btoday
TAM · 2033$8.32Bforecast
CAGR9.3%2027–2033
Cumulative$53.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.32BTotal addressable market
SAM$2.93BServiceable available market
SOM$497MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.3% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.32BLarge & growingTAM by 2033 at 9.3% CAGR
$2.93BServiceable nowreachable with today’s model
$497MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.49BBear6.0% CAGR
$8.32BBase9.3% CAGR
$10.7BBull12.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End-User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Soft Medical Robot Market — a $12.3B market by 2033. Plan: grow share from 9.1% to 15.3%.
Market size · 2033$12.3Btotal addressable
Market CAGR11.7%2027–2033
Target share15.3%from 9.1% today
Revenue ambition$1.89Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.1% | 15.3% | On track |
| Revenue | $1.03B | $1.89B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 37.1% | 43.6% | On track |
| Customer retention | 88.0% | 92.2% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End-User capability
A defensible second engine — invest in End-User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End-User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $200M capacity & capability investment
- Greenlight bolt-on M&A in End-User
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Soft Medical Robot Market conversation — a $2.69B market you can size, segment and defend in minutes.
Market size · 2033$2.69Btotal opportunity
Growth5.3%CAGR to 2033
Addressable buyers916+accounts in scope
Typical ROI7.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.1×return on cost, year one
< 3 mopayback period
$97K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
MedtronicIntuitive SurgicalStryker CorporationZimmer Biomet HoldingsSmith & NephewJohnson & Johnson (Ethicon)Boston ScientificVerb Surgical (a collaboration between Verily and Johnson & Johnson)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Soft Medical Robot Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Soft Medical Robot Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Soft Infusion Bags Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportSoft Hydrophilic Contact Lens Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportSoft Hip Protector Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportSoftgel Polishing System Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportSoftgel Manufacturing Machine Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportSoftgel Machine Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportSoftgel Encapsulation System Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportSoftgel Encapsulation Equipment Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportSoftgel Drying Tunnel Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportSoftgel Drying Systems Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportSoftgel CDMO Market
Softgel CDMO Market is valued at USD 1.65 Billion in 2025 and is expected to reach USD 2.6 Bill…
$1.7B market · 2025 base year
View reportSoftgel Capsules Polisher Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.